Disease Info Card

Lipid Metabolism Disorders

Information about Lipid Metabolism Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Lipid Metabolism Disorders

Most recent studies have shown that Lipid Metabolism Disorders shares some biological mechanisms with arteriosclerosis, atherosclerosis, cardiovascular-diseases, coronary-artery-disease, coronary-heart-disease, diabetes-mellitus, diabetes-mellitus-non-insulin-dependent, dyslipidemias, heart-diseases, hypercholesterolemia, hypercholesterolemia-familial, hyperlipidemia, hyperlipoproteinemias, hypertensive-disease, infarction, insulin-resistance, kidney-diseases, metabolic-diseases, myocardial-infarction, obesity.

Among the many pathways, these few ones have gauged particular interests from scientists studying Lipid Metabolism Disorders, and have been seen in publications frequently: Aging, Cell Death, Cholesterol Efflux, Cholesterol Homeostasis, Cholesterol Transport, Coagulation, Energy Homeostasis, Excretion, Fatty Acid Oxidation, Glucose Homeostasis, Insulin Secretion, Lipid Homeostasis, Lipid Storage, Lipid Transport, Localization, Menopause, Pathogenesis, Reverse Cholesterol Transport, Secretion, Transport

Quite a number of genes have been found to play important roles in Lipid Metabolism Disorders, such as APOA1, APOB, APOC3, APOE, CD55, HMGCR, INS, LCAT, LCP1, LDLR, LIPC, LPA, LPL, PPARA, PPARG, SEPSECS, TCN2, TG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.